Ellen Leich
Impact in
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Lymphoma Diagnosis and Treatment 30
- Hematology 17
- Multiple Myeloma Research and Treatments 17
- Co-authors
- Andreas Rosenwald (37 shared papers)German Ott (14 shared papers)Heike Horn (6 shared papers)Silviu Sbiera (5 shared papers)Cristina Lucia Ronchi (5 shared papers)Bruno Allolio (5 shared papers)Martin Faßnacht (5 shared papers)Ralf Christian Bargou (13 shared papers)
- Journals
- Blood (9 papers)Leukemia (6 papers)Haematologica (6 papers)Blood Cancer Journal (4 papers)Nature Communications (3 papers)
- Partner nations
- GermanyUnited StatesSpain
In The Last Decade
Ellen Leich
64 papers receiving 3.1k citations
Ellen Leich's Hit Papers
Peers
Comparison fields: 5 of 85
- Pathology and Forensic Medicine 1.4k
- Cancer Research 294
- Hematology 252
- Oncology 313
- Endocrine and Autonomic Systems 65
Countries citing papers authored by Ellen Leich
This map shows the geographic impact of Ellen Leich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen Leich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen Leich more than expected).
Fields of papers citing papers by Ellen Leich
This network shows the impact of papers produced by Ellen Leich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen Leich. The network helps show where Ellen Leich may publish in the future.
Co-authors
The 25 scholars most cited alongside Ellen Leich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry Hit paper breakdown → | 2015 | 512 |
| 2 | 2009 | 165 | |
| 3 | 2015 | 164 | |
| 4 | 2011 | 126 | |
| 5 | 2019 | 114 | |
| 6 | 2008 | 112 | |
| 7 | 2022 | 109 | |
| 8 | 2018 | 104 | |
| 9 | 2011 | 98 | |
| 10 | 2016 | 98 | |
| 11 | 2010 | 91 | |
| 12 | 2015 | 87 | |
| 13 | 2007 | 86 | |
| 14 | 2013 | 76 | |
| 15 | 2011 | 73 | |
| 16 | 2007 | 66 | |
| 17 | 2014 | 59 | |
| 18 | 2013 | 53 | |
| 19 | 2013 | 50 | |
| 20 | 2013 | 49 |
About Ellen Leich
Ellen Leich is a scholar working on Pathology and Forensic Medicine, Hematology, Cancer Research, Immunology and Allergy and Surgery, having authored 66 papers that have together received 3.1k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (30 papers), Multiple Myeloma Research and Treatments (17 papers), Adrenal and Paraganglionic Tumors (5 papers), Endoplasmic Reticulum Stress and Disease (2 papers), Cancer-related Molecular Pathways (2 papers), Cell Adhesion Molecules Research (2 papers), MicroRNA in disease regulation (2 papers) and Signaling Pathways in Disease (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (1.4k citations), Cancer Research (294 citations), Hematology (252 citations), Oncology (313 citations) and Endocrine and Autonomic Systems (65 citations). Ellen Leich has collaborated with scholars based in Germany, United States and Spain. Frequent co-authors include Andreas Rosenwald, German Ott, Heike Horn, Silviu Sbiera, Cristina Lucia Ronchi, Bruno Allolio, Martin Faßnacht, Ralf Christian Bargou, Jörg Kalla and Tiemo Katzenberger. Their work appears in journals such as Blood, Leukemia, Haematologica, Blood Cancer Journal and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.